Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from CellaVision AB ( (SE:CEVI) ).
CellaVision’s annual general meeting in Lund approved the 2025 financial statements and granted discharge from liability to the board and CEO, while confirming a dividend of SEK 2.75 per share to be paid in early May. The meeting also decided that the board will consist of six members and one auditor without deputies, maintaining overall governance continuity.
Shareholders re-elected five board members, appointed industry executive Zlatko Rihter as both new director and chairman, and renewed KPMG as auditor, while also approving standard remuneration terms for directors, committee work and the auditor. The AGM further extended existing nomination committee principles through 2027 and authorized the board to repurchase up to 10% of the company’s shares, giving it added flexibility to optimize capital structure, secure working capital and broaden ownership, which may support shareholder value over time.
More about CellaVision AB
CellaVision is a global medical technology company that develops and sells automated systems for routine analysis of blood and other body fluids used in healthcare diagnostics. Its products, based on expertise in sample preparation, image analysis, artificial intelligence and automated microscopy, replace manual lab work and support efficient workflows across more than 40 countries via global partners and 13 local market organizations.
The Lund-based company reported 2025 sales of SEK 759 million and targets average annual growth of 15% over an economic cycle. CellaVision’s solutions are used in the diagnosis of infections and serious cancers, and its shares are listed on the Nasdaq Stockholm Mid Cap list, underscoring its established position in the medical diagnostics technology market.
Average Trading Volume: 46,146
Technical Sentiment Signal: Sell
Current Market Cap: SEK2.87B
For a thorough assessment of CEVI stock, go to TipRanks’ Stock Analysis page.